The Journal of Immunology, Vol 141, Issue 12 4229-4234, Copyright © 1988 by American Association of Immunologists

ARTICLES

IFN-gamma, tumor necrosis factor-alpha, and urokinase regulate the expression of urokinase receptors on human monocytes

JC Kirchheimer, YH Nong and HG Remold
Department of Rheumatology and Immunology, Brigham and Women's Hospital, Boston, MA 02115.

The ability of macrophages to reach inflammatory loci is crucial in the function of cellular immunity. Invasive properties of macrophages may be due to the proteinase urokinase which binds to cell surface receptors, and thereby confers on macrophages the capacity for localized proteolysis of the interstitium. Here, we investigated the role of the macrophage-activating factors IFN-gamma, TNF-alpha, and granulocyte-macrophage-CSF and of urokinase on the expression of urokinase receptors by human cultured monocytes. IFN-gamma and TNF- alpha induced increased urokinase binding to human cultured monocytes in a time- and dose-dependent fashion. At optimal concentrations, IFN- gamma (200 U/ml) increased the number of receptors/cell from 14,000 to 64,000, TNF-alpha (50 U/ml) to 30,000, and combinations of IFN-gamma and TNF-alpha to 90,000. Granulocyte-macrophage-CSF had no effect. The enhanced urokinase binding is due to increased numbers of urokinase receptors and not an increased affinity of the receptor for urokinase. In the presence of urokinase during monocyte activation, IFN-gamma induced only 25,000 receptors/cell. However, urokinase does not inhibit increased receptor expression when the cells are activated with TNF- alpha. The effect of urokinase on induction of urokinase receptors by combinations of IFN-gamma and TNF-alpha varied with the dosage of TNF- alpha: A combination of IFN-gamma (200 U/ml) and TNF-alpha (15 U/ml) induced 38,000 receptors/cell in the presence and 90,000 receptors/cells in the absence of urokinase, whereas IFN-gamma (200 U/ml) and TNF-alpha (20 U/ml) induced 90,000 receptors/cell in the absence and presence of urokinase. These studies demonstrate that IFN- gamma, TNF-alpha, and urokinase collectively regulate the number of urokinase receptors on human monocytes. The induction of urokinase receptors may be responsible for increased invasiveness of the activated macrophage.

This article has been cited by other articles:

				H Kliem, H Welter, W D Kraetzl, M Steffl, H H D Meyer, D Schams, and B Berisha Expression and localisation of extracellular matrix degrading proteases and their inhibitors during the oestrous cycle and after induced luteolysis in the bovine corpus luteum Reproduction, September 1, 2007; 134(3): 535 - 547. [Abstract] [Full Text] [PDF]

				H. Kobayashi, T. Yagyu, T. Kondo, N. Kurita, K. Inagaki, S. Haruta, R. Kawaguchi, T. Kitanaka, Y. Sakamoto, Y. Yamada, et al. Suppression of Urokinase Receptor Expression by Thalidomide Is Associated with Inhibition of Nuclear Factor {kappa}B Activation and Subsequently Suppressed Ovarian Cancer Dissemination Cancer Res., November 15, 2005; 65(22): 10464 - 10471. [Abstract] [Full Text] [PDF]

				R. Balabanov, D. Lisak, T. Beaumont, R. P. Lisak, and P. Dore-Duffy Expression of Urokinase Plasminogen Activator Receptor on Monocytes from Patients with Relapsing-Remitting Multiple Sclerosis: Effect of Glatiramer Acetate (Copolymer 1) Clin. Vaccine Immunol., November 1, 2001; 8(6): 1196 - 1203. [Abstract] [Full Text] [PDF]

				T. S. Mahoney, A. S. Weyrich, D. A. Dixon, T. McIntyre, S. M. Prescott, and G. A. Zimmerman Cell adhesion regulates gene expression at translational checkpoints in human myeloid leukocytes PNAS, August 17, 2001; (2001) 181201398. [Abstract] [Full Text] [PDF]

				R. G. Sitrin, P. M. Pan, H. A. Harper, R. F. Todd III, D. M. Harsh, and R. A. Blackwood Clustering of Urokinase Receptors (uPAR; CD87) Induces Proinflammatory Signaling in Human Polymorphonuclear Neutrophils J. Immunol., September 15, 2000; 165(6): 3341 - 3349. [Abstract] [Full Text] [PDF]

				P. E. P. Dekkers, T. ten Hove, A. A. te Velde, S. J. H. van Deventer, and T. van der Poll Upregulation of Monocyte Urokinase Plasminogen Activator Receptor during Human Endotoxemia Infect. Immun., April 1, 2000; 68(4): 2156 - 2160. [Abstract] [Full Text] [PDF]

				R. G. Sitrin, P. M. Pan, H. A. Harper, R. A. Blackwood, and R. F. Todd III Urokinase Receptor (CD87) Aggregation Triggers Phosphoinositide Hydrolysis and Intracellular Calcium Mobilization in Mononuclear Phagocytes J. Immunol., December 1, 1999; 163(11): 6193 - 6200. [Abstract] [Full Text] [PDF]

				C. Bouchet, K. Hacene, P.-M. Martin, V. Becette, M. Tubiana-Hulin, S. Lasry, J. Oglobine, and F. Spyratos Dissemination Risk Index Based on Plasminogen Activator System Components in Primary Breast Cancer J. Clin. Oncol., October 1, 1999; 17(10): 3048 - 3057. [Abstract] [Full Text] [PDF]

				C.-I W. Q. Y. and Charles S. Craik and C. I. Wang Isolation of a High Affinity Inhibitor of Urokinase-type Plasminogen Activator by Phage Display of Ecotin J. Biol. Chem., May 19, 1995; 270(20): 12250 - 12256. [Abstract] [Full Text] [PDF]

				X.-N. Li, V. K. Varma, J. M. Parks, R. L. Benza, J. C. Koons, J. R. Grammer, H. Grenett, E. M. Tabengwa, and F. M. Booyse Thrombin Decreases the Urokinase Receptor and Surface-Localized Fibrinolysis in Cultured Endothelial Cells Arterioscler. Thromb. Vasc. Biol., March 1, 1995; 15(3): 410 - 419. [Abstract] [Full Text]

				T. S. Mahoney, A. S. Weyrich, D. A. Dixon, T. McIntyre, S. M. Prescott, and G. A. Zimmerman Cell adhesion regulates gene expression at translational checkpoints in human myeloid leukocytes PNAS, August 28, 2001; 98(18): 10284 - 10289. [Abstract] [Full Text] [PDF]